Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer
US9891223B2 · kind B2 · utility
7Cited by
10References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2008 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | Jul 10, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/811
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Leukocyte Elastase Inhibitor tumor marker in a biological sample taken from a patient suspected of having colorectal cancer. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.